Viable skin efficiently absorbs and metabolizes bisphenol A.
Zalko
Daniel
D
INRA, UMR1089 Xénobiotiques, 180 Chemin de Tournefeuille, BP 93173, 31027 Toulouse Cedex 3, France. dzalko@toulouse.inra.fr
Jacques
Carine
C
Duplan
Hélène
H
Bruel
Sandrine
S
Perdu
Elisabeth
E
D000328:Adult; D000818:Animals; D001559:Benzhydryl Compounds; D002250:Carbon Radioisotopes; D004305:Dose-Response Relationship, Drug; D052244:Endocrine Disruptors / Q000378:metabolism / Q000493:pharmacokinetics* / Q000633:toxicity; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008954:Models, Biological; D010636:Phenols / Q000378:metabolism / Q000493:pharmacokinetics* / Q000633:toxicity; D011851:Radioactivity; D012867:Skin / Q000187:drug effects / Q000378:metabolism*; D013552:Swine; D000098826:Bisphenol A Compounds
D001559:Benzhydryl Compounds; D002250:Carbon Radioisotopes; D052244:Endocrine Disruptors; D010636:Phenols; C006780:bisphenol A; D000098826:Bisphenol A Compounds